| Name | Title | Contact Details |
|---|
A Community of Patients & Physicians Redesigning Healthcare Together
Denison is a uranium exploration and development company with interests in exploration and development projects in Canada, Zambia, Mali, Namibia and Mongolia. Including its 60% owned Wheeler project, which hosts the high grade Phoenix uranium deposit, Denison`s exploration project portfolio consists of numerous projects covering over 470,000 hectares in the eastern Athabasca Basin region of Saskatchewan. Denison`s interests in Saskatchewan also include a 22.5% ownership interest in the McClean Lake joint venture, which includes several uranium deposits and the McClean Lake uranium mill, one of the world`s largest uranium processing facilities, plus a 25.17% interest in the Midwest deposit and a 60% interest in the J Zone deposit on the Waterbury property. Both the Midwest and J Zone deposits are located within 20 kilometres of the McClean Lake mill. Internationally, Denison owns 100% of the conventional heap leach Mutanga project in Zambia, 100% of the uranium/copper/silver Falea project in Mali, a 90% interest in the Dome project in Namibia, and an 85% interest in the in-situ recovery projects held by the GSJV in Mongolia. Denison is engaged in mine decommissioning and environmental services through its DES division and is the manager of UPC, a publicly traded company which invests in uranium oxide and uranium hexafluoride.
Dek Consulting is a Mayfield, KY-based company in the Business Services sector.
Heritage Ridge Golf Club Of Ho is a Hobe Sound, FL-based company in the Business Services sector.
Tyber Medical LLC is an orthopedic device manufacturer based in Bethlehem, Pennsylvania, established in 2012. The company specializes in providing FDA-cleared and CE-marked private-label orthopedic implants, focusing on the spinal, extremity, and trauma markets. Tyber Medical has developed over 50 systems, including advanced spinal implants like PEEK Titanium Plasma-coated cervical cages, which have demonstrated a fusion rate exceeding 98%. The company offers a range of products, including trauma and extremity plating systems, and provides development and manufacturing services for med-tech Original Equipment Manufacturers (OEMs). Tyber Medical aims to facilitate quick product launches, typically averaging 12 months from signing to market. Recently, the company merged with Intech and Resolve Surgical Technologies to enhance its capabilities in the musculoskeletal device industry, improving innovation and supply chain resiliency. Tyber Medical serves healthcare providers and distributors globally, supporting improved patient outcomes through advanced implant technologies.